Sarah Fashena

Title: The Innovative Contributions of Sarah Fashena

Introduction

Sarah Fashena is a notable inventor based in Jenkintown, Pennsylvania. She has made significant contributions to the field of cellular biology through her innovative research and patents. Her work focuses on understanding cellular morphology, locomotion, and death, which are critical areas in medical research.

Latest Patents

Sarah Fashena holds a patent titled "Methods for identifying agents which affect cellular morphology, locomotion and death." This patent involves an isolated nucleic acid molecule that encodes a mammalian signal mediator protein known as HEF-1. This protein plays a vital role in regulating cellular morphological alterations. The invention includes a protein with an amino-terminal SH3 domain, an internal domain containing several SH2 binding motifs, and a carboxy-terminal effector domain that can induce pseudohyphal budding in yeast. The biological molecules described in the patent are valuable as research tools and as diagnostic and therapeutic agents for identifying, detecting, and regulating complex signaling events that lead to morphological, potentially neoplastic, cellular changes. Sarah Fashena has 1 patent to her name.

Career Highlights

Sarah Fashena is affiliated with the Fox Chase Cancer Center, where she conducts her research. Her work at this esteemed institution has allowed her to contribute to advancements in cancer research and cellular biology.

Collaborations

Throughout her career, Sarah has collaborated with notable colleagues, including Erica A. Golemis and Geraldine O'Neill. These collaborations have further enriched her research and expanded the impact of her work in the scientific community.

Conclusion

In summary, Sarah Fashena is an accomplished inventor whose work has significantly advanced our understanding of cellular processes. Her innovative patent and contributions to cancer research highlight her importance in the field.